Drugs / FLU-Q-PAN H7N9 Formulation 3
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04789577 Comparator | Mar 2021 → Sep 2022 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLU-Q-PAN H7N9 Formulation 3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04789577 ↗ |
| Modality | Vaccine | “FLU-Q-PAN H7N9 Formulation 3 vaccine” NCT04789577 ↗ |